Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults
1 other identifier
observational
4,000
1 country
1
Brief Summary
The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 17, 2021
CompletedFirst Submitted
Initial submission to the registry
February 19, 2021
CompletedFirst Posted
Study publicly available on registry
February 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 6, 2022
CompletedNovember 3, 2022
November 1, 2022
1.4 years
February 19, 2021
November 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HPV Vaccine Knowledge
Data from survey will describe HPV and HPV vaccine knowledge, health beliefs, attitudes, affect, health literacy, health care experiences, vaccine discussions and information sources, preparedness for shared decision-making and HPV vaccine uptake and intentions and examine relationships between these variables among a national sample of U.S. adults (N=4,000) ages 18-45 years.
Day 1
HPV-Related Educational Intervention Preferences
Data from survey will describe intervention preferences and associations between intervention preferences and sociodemographic variables (e.g., age, gender, race, ethnicity, socioeconomic status, employment status, parental status, and insurance status).
Day 1
Study Arms (2)
Males and Females ages 18-26
Participants between the ages of 18-26 will complete a survey
Males and Females ages 27-45
Participants between the ages of 27-45 will complete a survey
Interventions
Data will be obtained via self-report from participants via a one-time Qualtrics survey.
Eligibility Criteria
Participants living throughout the United States
You may qualify if:
- Age 18-45
- Living in the United States
- a KnowledgePanel panelist directly or via verified partners
- Have internet access
- Able to read, write and understand English
- Individuals can participant regardless of their HPV vaccination status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moffitt Cancer Center
Tampa, Florida, 33612, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shannon M Christy, PhD
Moffitt Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2021
First Posted
February 23, 2021
Study Start
February 17, 2021
Primary Completion
July 6, 2022
Study Completion
July 6, 2022
Last Updated
November 3, 2022
Record last verified: 2022-11